相关实验视频

Updated: Jul 16, 2025

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

15.0K

预防阿尔茨海默病的精准医学:对ADAPT研究的分析

Sid E O'Bryant1,2, Fan Zhang1,2, Leigh A Johnson1,3

  • 1Institute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX, USA.

Journal of Alzheimer's disease : JAD
|September 18, 2023
PubMed
概括

这项研究确定了准确的血液生物标志物概况,以预测阿尔茨海默病的治疗反应. 这些发现支持用于阿尔茨海默氏症预防和治疗的精准医学方法.

关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.生物信息学是一种生物信息学.生物标志物 生物标志物临床试验临床试验临床试验临床试验临床试验这是一种炎症炎症炎症炎症.精准医学是一门精准医学.预防 预防 预防蛋白质组学 蛋白质组学

更多相关视频

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.0K

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212